377 related articles for article (PubMed ID: 30617096)
1. Investigation of Novel
Gerson S; Betts JW; Lucaßen K; Nodari CS; Wille J; Josten M; Göttig S; Nowak J; Stefanik D; Roca I; Vila J; Cisneros JM; La Ragione RM; Seifert H; Higgins PG
Antimicrob Agents Chemother; 2019 Mar; 63(3):. PubMed ID: 30617096
[TBL] [Abstract][Full Text] [Related]
2. Diversity of amino acid substitutions in PmrCAB associated with colistin resistance in clinical isolates of Acinetobacter baumannii.
Gerson S; Lucaßen K; Wille J; Nodari CS; Stefanik D; Nowak J; Wille T; Betts JW; Roca I; Vila J; Cisneros JM; Seifert H; Higgins PG
Int J Antimicrob Agents; 2020 Mar; 55(3):105862. PubMed ID: 31837449
[TBL] [Abstract][Full Text] [Related]
3. Dissecting Colistin Resistance Mechanisms in Extensively Drug-Resistant Acinetobacter baumannii Clinical Isolates.
Trebosc V; Gartenmann S; Tötzl M; Lucchini V; Schellhorn B; Pieren M; Lociuro S; Gitzinger M; Tigges M; Bumann D; Kemmer C
mBio; 2019 Jul; 10(4):. PubMed ID: 31311879
[TBL] [Abstract][Full Text] [Related]
4. Molecular Mechanisms of Colistin Resistance Among Pandrug-Resistant Isolates of Acinetobacter baumannii with High Case-Fatality Rate in Intensive Care Unit Patients.
Haeili M; Kafshdouz M; Feizabadi MM
Microb Drug Resist; 2018 Nov; 24(9):1271-1276. PubMed ID: 29590004
[TBL] [Abstract][Full Text] [Related]
5. Emergence of colistin-resistance in extremely drug-resistant Acinetobacter baumannii containing a novel pmrCAB operon during colistin therapy of wound infections.
Lesho E; Yoon EJ; McGann P; Snesrud E; Kwak Y; Milillo M; Onmus-Leone F; Preston L; St Clair K; Nikolich M; Viscount H; Wortmann G; Zapor M; Grillot-Courvalin C; Courvalin P; Clifford R; Waterman PE
J Infect Dis; 2013 Oct; 208(7):1142-51. PubMed ID: 23812239
[TBL] [Abstract][Full Text] [Related]
6. Phosphoethanolamine modification of lipid A in colistin-resistant variants of Acinetobacter baumannii mediated by the pmrAB two-component regulatory system.
Beceiro A; Llobet E; Aranda J; Bengoechea JA; Doumith M; Hornsey M; Dhanji H; Chart H; Bou G; Livermore DM; Woodford N
Antimicrob Agents Chemother; 2011 Jul; 55(7):3370-9. PubMed ID: 21576434
[TBL] [Abstract][Full Text] [Related]
7. ISAba1-dependent overexpression of eptA in clinical strains of Acinetobacter baumannii resistant to colistin.
Potron A; Vuillemenot JB; Puja H; Triponney P; Bour M; Valot B; Amara M; Cavalié L; Bernard C; Parmeland L; Reibel F; Larrouy-Maumus G; Dortet L; Bonnin RA; Plésiat P
J Antimicrob Chemother; 2019 Sep; 74(9):2544-2550. PubMed ID: 31199431
[TBL] [Abstract][Full Text] [Related]
8. Genetic and virulence characterization of colistin-resistant and colistin-sensitive A. baumannii clinical isolates.
Leite GC; Stabler RA; Neves P; Perdigão Neto LV; Ruedas Martins RC; Rizek C; Rossi F; Levin AS; Costa SF
Diagn Microbiol Infect Dis; 2019 Sep; 95(1):99-101. PubMed ID: 31178071
[TBL] [Abstract][Full Text] [Related]
9. In Vivo Selection of Pan-Drug Resistant Acinetobacter baumannii during Antibiotic Treatment.
Kim Y; Bae IK; Jeong SH; Yong D; Lee K
Yonsei Med J; 2015 Jul; 56(4):928-34. PubMed ID: 26069113
[TBL] [Abstract][Full Text] [Related]
10. Genomic investigation unveils colistin resistance mechanism in carbapenem-resistant
Vijayakumar S; Swetha RG; Bakthavatchalam YD; Vasudevan K; Abirami Shankar B; Kirubananthan A; Walia K; Ramaiah S; Biswas I; Veeraraghavan B; Anbarasu A
Microbiol Spectr; 2024 Feb; 12(2):e0251123. PubMed ID: 38214512
[TBL] [Abstract][Full Text] [Related]
11. Emergence of High-Level Colistin Resistance in an Acinetobacter baumannii Clinical Isolate Mediated by Inactivation of the Global Regulator H-NS.
Deveson Lucas D; Crane B; Wright A; Han ML; Moffatt J; Bulach D; Gladman SL; Powell D; Aranda J; Seemann T; Machado D; Pacheco T; Marques T; Viveiros M; Nation R; Li J; Harper M; Boyce JD
Antimicrob Agents Chemother; 2018 Jul; 62(7):. PubMed ID: 29712662
[TBL] [Abstract][Full Text] [Related]
12. A novel mutation in pmrB mediates colistin resistance during therapy of Acinetobacter baumannii.
Dahdouh E; Gómez-Gil R; Sanz S; González-Zorn B; Daoud Z; Mingorance J; Suárez M
Int J Antimicrob Agents; 2017 Jun; 49(6):727-733. PubMed ID: 28438568
[TBL] [Abstract][Full Text] [Related]
13. Colistin Heteroresistance and Involvement of the PmrAB Regulatory System in Acinetobacter baumannii.
Charretier Y; Diene SM; Baud D; Chatellier S; Santiago-Allexant E; van Belkum A; Guigon G; Schrenzel J
Antimicrob Agents Chemother; 2018 Sep; 62(9):. PubMed ID: 29914966
[TBL] [Abstract][Full Text] [Related]
14. Promoters of Colistin Resistance in
Nurtop E; Bayındır Bilman F; Menekse S; Kurt Azap O; Gönen M; Ergonul O; Can F
Microb Drug Resist; 2019 Sep; 25(7):997-1002. PubMed ID: 30964377
[No Abstract] [Full Text] [Related]
15. PmrB mutations including a novel 10-amino acid repeat sequence insertion associated with low-level colistin resistance in carbapenem-resistant Acinetobacter baumannii.
Lunha K; Thet KT; Ngudsuntia A; Charoensri N; Lulitanond A; Tavichakorntrakool R; Wonglakorn L; Faksri K; Chanawong A
Infect Genet Evol; 2020 Nov; 85():104577. PubMed ID: 33007498
[TBL] [Abstract][Full Text] [Related]
16. Contribution of Novel Amino Acid Alterations in PmrA or PmrB to Colistin Resistance in
Sato T; Shiraishi T; Hiyama Y; Honda H; Shinagawa M; Usui M; Kuronuma K; Masumori N; Takahashi S; Tamura Y; Yokota SI
Antimicrob Agents Chemother; 2018 Sep; 62(9):. PubMed ID: 29914952
[TBL] [Abstract][Full Text] [Related]
17. Genetic alterations in the pmrAB two-component system and lipid A biosynthesis genes of polymyxin-resistant Acinetobacter baumannii isolates.
El Mrimar N; Belouad EM; Benaissa E; Bssaibis F; Jazouli M; El Alaoui MA; Maleb A; Elouennass M
Acta Microbiol Immunol Hung; 2024 Jul; 71(2):134-139. PubMed ID: 38837239
[TBL] [Abstract][Full Text] [Related]
18. Correlation between overexpression and amino acid substitution of the PmrAB locus and colistin resistance in Acinetobacter baumannii.
Park YK; Choi JY; Shin D; Ko KS
Int J Antimicrob Agents; 2011 Jun; 37(6):525-30. PubMed ID: 21497062
[TBL] [Abstract][Full Text] [Related]
19. Emergence of colistin resistance without loss of fitness and virulence after prolonged colistin administration in a patient with extensively drug-resistant Acinetobacter baumannii.
Durante-Mangoni E; Del Franco M; Andini R; Bernardo M; Giannouli M; Zarrilli R
Diagn Microbiol Infect Dis; 2015 Jul; 82(3):222-6. PubMed ID: 25858028
[TBL] [Abstract][Full Text] [Related]
20. In vivo emergence of colistin resistance in Acinetobacter baumannii clinical isolates of sequence type 357 during colistin treatment.
Kim Y; Bae IK; Lee H; Jeong SH; Yong D; Lee K
Diagn Microbiol Infect Dis; 2014 Jul; 79(3):362-6. PubMed ID: 24809861
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
